Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ranitidine 150mg tablets
0103010T0AAAAAA
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | 4,477 |
|
Ranitidine 300mg tablets
0103010T0AAACAC
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | 3,092 |
|
Ranitidine 75mg/5ml oral solution sugar free
0103010T0AAAEAE
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | 156 |
|
Ranitidine 150mg effervescent tablets
0103010T0AAAIAI
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | 78 |
|
Ranitidine 75mg tablets
0103010T0AAAPAP
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | 64 |
|
Ranitidine 150mg/5ml oral solution sugar free
0103010T0AABUBU
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | 48 |
|
Ranitidine 5mg/5ml oral suspension
0103010T0AABRBR
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | 25 |
|
Ranitidine 5mg/5ml oral solution
0103010T0AABQBQ
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | 24 |
|
Ranitidine 300mg effervescent tablets
0103010T0AAAJAJ
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | 23 |
|
Ranitidine 75mg/5ml oral liquid
0103010T0AABABA
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | 15 |
|
Zantac 150mg tablets
0103010T0BBAAAA
|
Zantac | Ranitidine hydrochloride | Gastro-Intestinal System | 10 |
|
Ranitidine 50mg/2ml solution for injection ampoules
0103010T0AAADAD
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | 5 |
|
Rantec 150 tablets
0103010T0BGAAAA
|
Rantec | Ranitidine hydrochloride | Gastro-Intestinal System | 2 |
|
Zantac 300mg tablets
0103010T0BBACAC
|
Zantac | Ranitidine hydrochloride | Gastro-Intestinal System | 2 |
|
Gavilast 75mg tablets
0103010T0BUAAAP
|
Gavilast | Ranitidine hydrochloride | Gastro-Intestinal System | 1 |
|
Histac 150mg tablets
0103010T0BIAAAA
|
Histac | Ranitidine hydrochloride | Gastro-Intestinal System | 1 |
|
Ranitidine 10mg/5ml oral liquid
0103010T0AAAYAY
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | 1 |
|
Zantac 75 tablets
0103010T0BBAHAP
|
Zantac | Ranitidine hydrochloride | Gastro-Intestinal System | 1 |
|
Boots Heartburn Relief 75mg tablets
0103010T0BQABAP
|
Boots | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Gavilast Heartburn and Indigestion 75mg tablets
0103010T0BUABAP
|
Gavilast | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Gavilast-P 75mg tablets
0103010T0BTAAAP
|
Gavilast-P | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Histac 300mg tablets
0103010T0BIABAC
|
Histac | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Lloydspharmacy Heartburn & Indigestion Relief tablets
0103010T0BNABAP
|
Lloydspharmacy (Ranitidine) | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Lloydspharmacy Indigestion Relief 75mg tablets
0103010T0BNAAAP
|
Lloydspharmacy (Ranitidine) | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Raciran 150 tablets
0103010T0BEAAAA
|
Raciran | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.